UBS Group »

Pasithea Therapeutics Corp shares owned by UBS Group

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Pasithea Therapeutics Corp

May 2024Jul 2024Sep 2024Nov 2024Jan 2025010k20k30k40k05k10k
Value ($)Share countHistorical KTTA position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $41k 13k 3.15
2024-09-30 $36k 6.6k 5.42
2024-06-30 $191 38 5.05
2024-03-31 $4.4k 608 7.25

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Pasithea Therapeutics Corp

Armistice Capital
UBS Group
Tower Research Capital
Morgan Stanley
Royal Bank of Canada
Jpmorgan Chase & Co
Bank of America Corporation

View all funds holding Pasithea Therapeutics Corp